Compare Align Technology, Inc. (ALGN) vs AngloGold Ashanti Limited (AU) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Align Technology, Inc. vs AngloGold Ashanti Limited — how do they compare? Align Technology, Inc. trades at $176.3 (market cap $13.27B), while AngloGold Ashanti Limited trades at $79.27 (market cap $41.50B). The key difference: AngloGold Ashanti Limited is far larger — about 3.1× Align Technology, Inc.'s market cap, and AngloGold Ashanti Limited pays a 5.6% dividend while Align Technology, Inc. pays none. Which is the better fit depends on your goals.
| ALGN | AU | |
|---|---|---|
Market Cap | $13.27B | $41.50B |
Sector | Health | Basic Materials |
52-Week High | $207.19 | $128.26 |
52-Week Low | $124.88 | $45.22 |
Enterprise Value | $12.32B | $40.63B |
Dividend Yield | — | 5.6% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALGN trades at $185.22, up 0.38% today, with a bullish technical signal and strong analyst consensus. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 results expected soon. Revenue remains stable around $4.0B, supported by a 67.57% gross margin and positive cash flow trends. Recent news highlights global expansion and product innovation, including a new manufacturing facility in India.
Outlook is positive with a $220.75 consensus price target, though risks include regulatory scrutiny from the European Commission and competitive pressures. The stock's valuation at a P/E of 31.65 reflects growth expectations, but investors should monitor execution on international growth and demand stability in North America.
AngloGold Ashanti (AU) trades at $82.01, down 3.12% on the day, near key support at $81. The stock shows strong fundamentals with 2025 revenue surging to $9.89B and net income reaching $2.64B, driving a robust 31.11% net margin. Recent Q1 2026 earnings beat expectations at $2.52 EPS, while the company announced a $1.16 dividend and a share repurchase program. Technical indicators signal bearish momentum with RSI at 80.83 suggesting overbought conditions, but analyst consensus remains bullish with a $118 price target.
Outlook is positive due to explosive revenue growth, high profitability, and shareholder returns, but risks include gold price volatility and execution challenges. The stock offers value with a P/E of 12.34, though technical weakness may pressure near-term performance. Institutional sentiment is supportive with 64% buy ratings, but investors should monitor gold market dynamics and cost inflation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →About AngloGold Ashanti Limited
Anglogold Ashanti Ltd is one of the largest gold miners. The company also produces silver and sulphuric acid as by-products. Its operating divisions are Africa, Australia, and the Americas. The firm generates a majority of its revenue from Africa which includes Ghana, Guinea, Mali, the Democratic Republic of the Congo, and Tanzania.
Read more on AU →
